1367074-79-0

Upstream product

• 1367074-74-5 (3S,4S)-tert-butyl 3-{{6-[bis(tert-butoxycarbonyl)amino]-4-methylpyridin-2-yl}methyl}-4-hydroxypyrrolidine-1-carboxylate 
• 1367074-75-6 (3S,4S)-tert-butyl 3-(allyloxy)-4-((6-(bis(tert-butoxycarbonyl)amino)-4-methylpyridin-2-yl)methyl)pyrrolidine-1-carboxylate 
• 1367074-76-7 (3S,4S)-tert-butyl 3-((6-(bis(tert-butoxycarbonyl)amino)-4-methylpyridin-2-yl)methyl)-4-(2-oxoethoxy)pyrrolidine-1-carboxylate 
• 61626-91-3 o-hydroxyphenylmethylamine hydrochloride 

Downstream Products

• 1367074-83-6 2-((2-((3S,4S)-4-((6-amino-4-methylpyridin-2-yl)methyl)-pyrrolidin-3-yloxy)ethylamino)methyl)phenol 

Relevant academic research and scientific papers

Intramolecular hydrogen bonding: A potential strategy for more bioavailable inhibitors of neuronal nitric oxide synthase

Selective neuronal nitric oxide synthase (nNOS) inhibitors have therapeutic applications in the treatment of numerous neurodegenerative diseases. Here we report the synthesis and evaluation of a series of inhibitors designed to have increased cell membran

Intramolecular Hydrogen-Bonded Nitric Oxide Synthase Inhibitors

Compounds and related compositions and methods as can be used to selectively inhibit neuronal nitric oxide synthase and as can be employed in the treatment of various neurodegenerative diseases.